Literature DB >> 7850988

Incidence of the apolipoprotein B-3500 mutation in Denmark.

P S Hansen1, B Nørgaard-Petersen, H Meinertz, H K Jensen, A B Hansen, I C Klausen, L U Gerdes, O Faergeman.   

Abstract

A total of 5000 consecutively samples newborn screening cards were anonymously selected for screening for the apolipoprotein B-3500 (apo B-3500) mutation, which causes familial defective apolipoprotein B-100 (FDB). The mutation was found in 5 of 5000 Danish children, of whom 2 were twins. This indicates a lower prevalence of this mutation in Danes than that reported in the UK, Germany, USA, Austria, Canada and especially Switzerland. Haplotype studies suggest that Caucasian subjects with the apo B-3500 mutation have a common founder. The apparently lower prevalence in Denmark than in Switzerland and Central Europe may indicate that the mutation was brought from these areas to Denmark after the initial settling of Denmark. In 101 unrelated Danish subjects with familial hypercholesterolemia, diagnosed on clinical and biochemical criteria including tendon xanthomata, 2 were heterozygous for the apo B-3500 mutation (2%).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7850988     DOI: 10.1016/0009-8981(94)90093-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Absence of apolipoprotein B3500 mutation in type 2a hyperlipoproteinemia patients and in the general population from southern Italy.

Authors:  D Seripa; C Gravina; R Volpe; M Margaglione; S Papa; G Merla; P Parrella; G Di Minno; G Ricci; M Testa; V M Fazio
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Storage policies and use of the Danish Newborn Screening Biobank.

Authors:  B Nørgaard-Pedersen; D M Hougaard
Journal:  J Inherit Metab Dis       Date:  2007-07-12       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.